Activation of the coagulation cascade in C1-inhibitor deficiencies

Blood

Volumn 89, Issue 9, 1997, Pages 3213-3218

  Cugno, Massimo ^b   Cicardi, Marco ^b   Bottasso, Bianca ^b   Coppola, Raffaella ^b   Paonessa, Raffaella ^b   Mannucci, Pier Mannuccio ^b   Agostoni, Angelo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; HIGH MOLECULAR WEIGHT KININOGEN; PROTHROMBIN;

ADULT; AMINO TERMINAL SEQUENCE; ANGIONEUROTIC EDEMA; ANTICOAGULATION; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOSTASIS; HUMAN; MALE; PRIORITY JOURNAL; REMISSION;

EID: 0030968127     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.9.3213     Document Type: Article

References (39)

1. Davis AE III: C1 inhibitor and hereditary angioneurotic edema. Ann Rev Immunol 6:595, 1988
2. Agostoni A, Cicardi M: Hereditary and acquired C1-inhibitor deficiency: Biological and clinical characteristics in 235 patients. Medicine 71:206, 1992
3. Fields T, Ghebrehiwet B, Kaplan AP: Kinin formation in hereditary angioedema plasma: Evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin. J Allergy Clin Immunol 72:54, 1983
4. Shoemaker LR, Schurman SJ, Donaldson VH, Davis AE III: Hereditary angioneurotic oedema: Characterization of plasma kinin and vascular permeability-enhancing activities. Clin Exp Immunol 95:22, 1994
5. DeLa Cadena RA, Wachtfogel YT, Colman RW: Contact activation pathway: Inflammation and coagulation, in Colman RW, Hirsh J, Marder WJ, Salzman EW (eds): Hemostasis and Thrombosis: Principles and Clinical Practice. Philadelphia, PA, Lippincott, 1994, p 219
6. Donaldson VH, Ratnoff OD, Dias da Silva W, Rosen FS: Permeability-increasing activity in hereditary angioneurotic edema plasma. J Clin Invest 48:642, 1969
7. Donaldson VH, Rosen FS, Bing DH: Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (HANE) plasma. Trans Am Assoc Phys 90:174, 1977
8. Shapira M, Silver LD, Scott CF, Schmaier AH, Prograis LJ, Curd JG, Colman RW: Prekallikrein activation and high-molecular-weight-kininogen consumption in hereditary angioedema. N Engl J Med 308:1050, 1983
9. Kaufman N, Page JD, Pixley RA, Shein R, Shmaier AH, Colman RW: α 2-Macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis. Blood 77:2660, 1991
10. Berrettini M, Lammle B, White T, Heeb MJ, Schwarz HP, Zuraw B, Curd J, Griffin JH: Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. Blood 68:455, 1986
11. Cugno M, Hack CE, de Boer JP, Eerenberg AJM, Agostoni A, Cicardi M: Generation of plasmin during acute attacks of hereditary angioedema. J Lab Clin Med 121:38, 1993
12. Donaldson VH, Rosen FS: Hereditary angioneurotic edema: A clinical survey. Pediatrics 37:1017, 1966
13. Colman RW, Marder VJ, Salzman EW, Hirsh J: Overview of hemostasis, in Colman RW, Hirsh J, Marder WJ, Salzman EW (eds): Hemostasis and Thrombosis: Principles and Clinical Practice. Philadelphia, PA, Lippincott, 1994, p 3
14. Rapaport SI, Rao LVM: The tissue factor pathway: How it has become a "prima ballerina". Thromb Haemost 74:7, 1995
15. Nielsen EW, Morrissey J, Olsen JO, Osterud B: Factor VIIa in patients with C1-inhibitor deficiency. Thromb Haemost 74:1103, 1995
16. Garcia JGN, Siflinger-Birnboim A, Bizios R, Del Vecchio PJ, Fenton JW II, Malik AB: Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol 128:96. 1986
17. De Michele MAA, Moon DG, Fenton JW II, Minnear FL: Thrombin's enzymatic activity increases permeability of endothelial cell monolayers. J Appl Physiol 69:1599, 1990
18. Garcia JGN, Pavalko FM, Patterson CE: Vascular endothelial cell activation and permeability responses to thrombin. Blood Coagul Fibrinolysis 6:609, 1995
19. Bauer KA, Weitz JI: Laboratory markers of coagulation and fibrinolysis, in Colman RW, Hirsh J, Marder WJ, Salzman EW (eds): Hemostasis and Thrombosis: Principles and Clinical Practice. Philadelphia, PA, Lippincott, 1994, p 1197
20. Nuijens JH, Huijbregts CCM, Eerenberg-Belmer AJM, Abbink JJ, Strack van Schijndel RJM, Felt-Bersma RJF, Thijs LG, Hack CE: Quantification of plasma factor XIIa-C1-inhibitor and kallikrein-C1-inhibitor complexes in sepsis. Blood 72:1841, 1988
21. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U: Measurement of basal levels of factor Vila in hemophilia A and B patients. Blood 80:25, 1992
22. Ford RP, Esnouf MP, Burgess AI, Sarphie A: An enzyme linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman factor) in human plasma. J Immunoassay 17:119, 1996
23. Coppola R, Tombesi S, Valentini F, Alborali S, Albertini A, Mannucci PM: Enzyme-linked immunosorbent assay of human factor VII based upon a monoclonal antibody that recognizes the native conformation of the protein. Thromb Res 68:283, 1992
24. Donaldson VH: The challenge of hereditary angioneurotic edema. N Engl J Med 308:1094, 1983
25. Donaldson VH, Rosen FS: Action of complement in hereditary angioneurotic edema. The role of C' 1 esterase, J Clin Invest 43:2204, 1964
26. Cugno M, Nuijens J, Hack E, Eerenberg A, Frangi D, Agostoni A, Cicardi M: Plasma levels of C1 inhibitor complexes and cleaved C1 inhibitor in patients with hereditary angioneurotic edema. J Clin Invest 85:1215, 1990
27. Davie EW: Biochemical and molecular aspects of coagulation cascade. Thromb Haemost 74:1, 1995
28. Radcliffe R, Bagdasarian A, Colman R, Nemerson Y: Activation of bovine factor VII by Hageman factor fragments. Blood 50:611, 1977
29. Seligsohn U, Osterud B, Brown SF, Griffin JH, Rapaport SI: Activation of human factor VII in plasma and purified systems. J Clin Invest 64:1056, 1979
30. Teilet JM, Bauer KA, Lau HK, Rosenberg RD: Studies of prothrombin activation pathway utilizing radioimmunoassays for F2/ F1 + 2 fragment and the thrombin-antithrombin complex. Blood 59:1086, 1982
31. Boneu B, Bes G, Pelzer H, Sie P, Boccalon H: D-dimers, thrombin antithrombin III complexes and prothrombin fragment 1 + 2: Diagnostic value in clinical suspected deep vein thrombosis. Thromb Haemost 65:28, 1991
32. van Deventer SJH, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A: Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76:2520, 1990
33. Schaeffer RC Jr, Gong F, Bitrick MS Jr, Smith TL: Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms. Am J Physiol 264:H1798, 1993
34. Ehringer WD, Edwards MJ, Miller FN: Mechanisms of athrombin, histamine, and bradykinin induced endothelial permeability. J Cell Physiol 167:562, 1996
35. Donaldson VH: Blood coagulation and related plasma enzymes in inflammation. Ser Haemat 3:39, 1970
36. Cugno M, Cicardi M, Agostoni A: Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamk acid. J Allergy Clin Immunol 93:870. 1994
37. Cugno M, Bergamaschini L, Uziel L, Cicardi M, Agostoni A, Jie AFH, Kluft C: Haemostasis contact system and fibrinolysis in hereditary angioedema (C1-inhibitor deficiency). J Clin Chem Clin Biochem 26:423, 1988
38. Kleniewsky J, Blankenship DT, Cardin AD, Donaldson V: Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin. J Lab Clin Med 120:129, 1992
39. Kaplan AP, Austen KF: A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. J Exp Med 133:696, 1971